Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2014 Jul;140(1):123-9.

Role of 13C methacetin breath test for non invasive staging of liver fibrosis in patients with chronic hepatitis C

Carmen Fierbinteanu-Braticevici  1 , Raluca Papacocea, Laura Tribus, Baicus Cristian
Affiliations
Clinical Trial

Role of 13C methacetin breath test for non invasive staging of liver fibrosis in patients with chronic hepatitis C

Carmen Fierbinteanu-Braticevici et al. Indian J Med Res. 2014 Jul.

Abstract

Background & objectives: The development and evaluation of non invasive tests to assess liver fibrosis have been an active field of research. The present study was carried out to evaluate the role of 13C-methacetin breath test 13C-MBT) as a non invasive tool for liver fibrosis staging in patients with chronic hepatitis C (CHC).

Methods: 13C-Methacetin breath test was performed in 115 patients with CHC histologically proven and in 55 healthy controls. All patients and controls underwent routine liver function tests. The CHC patients underwent histological assesment of liver by percutaneous liver biopsy. The correlation between the 13C-methacetin breath test and liver biopsy was tested using Kendall's rank correlation coefficients. The overall validity was expressed as area under receiver operating characteristic curve (AUROC) with 95%CI.

Results: Delta over baseline values (DOB) of CHC patients at 20 min were significantly reduced compared with control (16. 2 vs. 21. 06%, p <0.001). There were also significant differences between CHC patients and controls as regard the metabolization speed (dose/h at 20 min (17.80 vs 28.6, p <0.001) and metabolization capacity (cumulative recovery after 60 min (13.8 vs 20.4 p <0.001). The best 13C-MBT parameter correlated with fibrosis was DOB at 20 min (r = -0.596). The optimal cut-off for the diagnosis of advanced fibrosis (F ≥ 3) was 15.2 per cent, with AUROC = 0.902, 95%CI: (0.851-0.938), a sensitivity of 82 per cent and a specificity of 80 per cent. DOB at 20 min predicted even better cirrhosis: AUROC = 0.932 95 per cent CI = 0.901-0.953, a sensitivity of 96 per cent and a specificity of 92 per cent.

Interpretation & conclusions: Based on our findings the 13C-methacetin breath test appears to be a promising tool to identify CHC patients with advanced fibrosis and to replace liver biopsy. Further studies need to be done to assess its potential to be used in regular clinical practice.

PubMed Disclaimer

Figures

Fig
Fig
ROC analysis of the 13C methacetin breath test to differentiate CHC patients from controls.
See this image and copyright information in PMC

References

    1. Mitchell AE, Colvin HM, Palmer Beasley R. Institute of Medicine recommendations for the prevention and control of hepatitis B and C. Hepatology. 2010;51:729–33. - PubMed
    1. Sanai FM, Keeffe EB. Liver biopsy for histological assessment - the case against. Saudi J Gastroenterol. 2010;16:124–32. - PMC - PubMed
    1. Tural C, Tor J, Sanvisens A, Pérez-Alvarez N, Martinez E, Ojanguren I, Garcia Samaniego J, et al. Accuracy of simple biochemical tests in identifying liver fibrosis in patients co-infected with human immunodeficiency virus and hepatitis C virus. Clin Gastroenterol Hepatol. 2009;7:339–45. - PubMed
    1. Faria SC, Ganesan K, Mwangi I, Shiehmorteza M, Viamonte B, Mazhar S, et al. MR imaging of liver fibrosis: curr state art. Radiographics. 2009;29:1615–35. - PMC - PubMed
    1. Fierbinteanu-Braticevici C, Andronescu D, Usvat R, Cretoiu D, Baicus C, Marinoschi G. Acoustic radiation force imaging sonoelastography for noninvasive staging of liver fibrosis. World J Gastroenterol. 2009;15:5525–32. - PMC - PubMed

Publication types